Clinical Trials Browser

Phase 2 × Pleural Effusion, Malignant × Bevacizumab × Clear all

NCT02054052 2019-03-29

Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Pericardial Effusion, Pleural Effusion, Malignant

NCT02942043 2018-11-07

Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer

Phase 2 Unknown

Pleural Effusion, Malignant

NCT02054078 2014-02-04

Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion

Phase 2 Unknown

Pleural Effusion, Malignant

NCT00343291 2011-06-07

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Phase 2 Completed

121 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant